Nafarelin Acetate and Benign Prostatic Hyperplasia
- 3 March 1988
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 318 (9) , 580-581
- https://doi.org/10.1056/nejm198803033180913
Abstract
Correspondence from The New England Journal of Medicine — Nafarelin Acetate and Benign Prostatic HyperplasiaKeywords
This publication has 12 references indexed in Scilit:
- Use of Luteinizing Hormone - Releasing Hormone Analogs in the Treatment of Hormone-Dependent TumorsSeminars in Reproductive Medicine, 1987
- The Effect of Nafarelin Acetate, a Luteinizing-Hormone–Releasing Hormone Agonist, on Benign Prostatic HyperplasiaNew England Journal of Medicine, 1987
- EFFECT OF A GNRH ANALOGUE (LEUPROLIDE) ON BENIGN PROSTATIC HYPERTROPHYJournal of Clinical Endocrinology & Metabolism, 1987
- Intratissular androgens in benign prostatic hyperplasia and prostatic cancerJournal of Steroid Biochemistry, 1986
- D-TRP-6-LH-RH TREATMENT OF ADVANCED PROSTATIC CANCERThe Lancet, 1986
- Testicular Histology After Prolonged Treatment with a Gonadotropin-Releasing Hormone AnalogueJournal of Urology, 1985
- Tissue content of dihydrotestosterone in human prostatic hyperplasis is not supranormal.Journal of Clinical Investigation, 1983
- Inhibition of serum androgen levels by chronic intranasal and subcutaneous administration of a potent luteinizing hormone-releasing hormone (LH-RH) agonist in adult menFertility and Sterility, 1982
- Reversible Inhibition of Testicular Steroidogenesis and Spermatogenesis by a Potent Gonadotropin-Releasing Hormone Agonist in Normal MenNew England Journal of Medicine, 1981
- The pathogenesis of benign prostatic hyperplasiaThe American Journal of Medicine, 1980